Search
Dare Bioscience Inc
DAREAdd to Watchlist
1.220USD
-0.020-1.61%
Close 07-31 16:00（ET）Quotes delayed by 15 min
16.99MMarket Cap
LossP/E TTM
More Details of Dare Bioscience Inc Company
Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.
Dare Bioscience Inc Info
Ticker SymbolDARE
Company nameDare Bioscience Inc
IPO dateApr 10, 2014
CEOJohnson (Sabrina Martucci)
Number of employees21
Security typeOrdinary Share
Fiscal year-endApr 10
Address3655 Nobel Dr Ste 260
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92122-1050
Phone18589267655
Websitehttps://www.darebioscience.com/
Ticker SymbolDARE
IPO dateApr 10, 2014
CEOJohnson (Sabrina Martucci)
Company Executives of Dare Bioscience Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
80.17K
--
Dr. William H. (Bill) Rastetter, Ph.D.
Dr. William H. (Bill) Rastetter, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
39.72K
+97.84%
Mr. Gregory W. (Greg) Matz, CPA
Mr. Gregory W. (Greg) Matz, CPA
Independent Director
Independent Director
30.85K
+99.86%
Ms. Jessica D. Grossman, M.D.
Ms. Jessica D. Grossman, M.D.
Independent Director
Independent Director
26.07K
--
Dr. Susan L. Kelley, M.D.
Dr. Susan L. Kelley, M.D.
Independent Director
Independent Director
23.70K
--
Dr. Robin J. Steele, J.D.
Dr. Robin J. Steele, J.D.
Independent Director
Independent Director
--
--
Ms. Mardee Haring-layton
Ms. Mardee Haring-layton
Chief Accounting Officer
Chief Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
80.17K
--
Dr. William H. (Bill) Rastetter, Ph.D.
Dr. William H. (Bill) Rastetter, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
39.72K
+97.84%
Mr. Gregory W. (Greg) Matz, CPA
Mr. Gregory W. (Greg) Matz, CPA
Independent Director
Independent Director
30.85K
+99.86%
Ms. Jessica D. Grossman, M.D.
Ms. Jessica D. Grossman, M.D.
Independent Director
Independent Director
26.07K
--
Dr. Susan L. Kelley, M.D.
Dr. Susan L. Kelley, M.D.
Independent Director
Independent Director
23.70K
--
Dr. Robin J. Steele, J.D.
Dr. Robin J. Steele, J.D.
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Dare Bioscience Inc?
The top five shareholders of Dare Bioscience Inc are: Ms. Sabrina Martucci Johnson
How many institutions hold shares of Dare Bioscience Inc (DARE)?
As of 2026Q1, 63 institutions hold shares of Dare Bioscience Inc, with a combined market value of approximately 1.25M, accounting for 8.57% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 191412.00.